Comment

Comment by eganist

Way out of my depth here, but I'm guessing the main hurdles to turning this into a drug are encapsulation in a way that survives injection (or better yet, ingestion) as well as either targeting of infected cells or at least ensuring that even if it touches every cell, it only affects HIV DNA?

Basically, what's needed to commercialize this?

parent eganist 2 years ago

Discussion

Live from the official Hacker News API

A modern reader for Hacker News · SvelteKit + Skeleton